Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

18.45 +0.01 (+0.05%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
24 25 Next >
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
Via Benzinga
Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM
From Teva Pharmaceutical Industries Limited
Via Business Wire
What Were Your Best And Worst Stock Buys? What Does The Zinger Nation Think?
Admitting to success is a lot easier than failure and when it comes to stocks, not only is there money involved, but also questioning your — or your advisor's — judgment. And then there is the advice... 
Via Benzinga
Good and Bad stock news
Microsoft is down because of an FTC investigation of its possible anti-competitive moves. 
Via Talk Markets
Futures Slide To Overnight Lows As Algos Spooked By EU Ban On Russian Coal
After initially trading sharply higher around the European open, US stock futures dropped to session lows as traders digested the latest developments in the Ukraine war. 
Via Talk Markets
Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ET on May 3, 2022
From Teva Pharmaceutical Industries Limited
Via Business Wire
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: 
Via Benzinga
Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022
Upgrades 
Via Benzinga
CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report
Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid... 
Via Benzinga
Teva Reaches Agreement With Florida to Settle the State’s Opioid-Related Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
Monday Markets News
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved. 
Via Talk Markets
Friday Markets News
Methane leaks in the Permian Basin are 6 times higher than estimates. 
Via Talk Markets
Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters
Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over 
Via Benzinga
Lucky Day
Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund. 
Via Talk Markets
Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill
Via Benzinga
Hopes For A Peace Accord
The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant. 
Via Talk Markets
Rhode Island's Opioid Trial Against Teva Begins Today: Reuters
The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) alleged responsibility for the opioid crisis begins jury... 
Via Benzinga
7 Drug Stocks to Consider After the Viatris Plunge
As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market. 
Via InvestorPlace
Viatris To Pay $264M As EpiPen Antitrust Litigation Settlement: Reuters
Viatris Inc (NASDAQ: VTRS), previously known as Mylan, has agreed to pay $264 million to resolve a class-action lawsuit alleging it engaged in a scheme to delay... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Putin on the brink
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott. 
Via Talk Markets
Red Ink
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph 
Via Talk Markets
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept... 
Via FinancialNewsMedia
Exposures COVID-19
A Receding tide
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient. 
Via Talk Markets
World Markets News For Thursday
Ericsson stock lost another 5.27% today in US markets. 
Via Talk Markets
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu... 
Via Benzinga
Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment
A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O... 
Via Benzinga
World Markets News For Monday
European markets were down over fear of Ukrainian battles. 
Via Talk Markets
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.